Increased GFAP levels in CSF and serum have also been seen in GBS; however, there have been conflicting results on whether GFAP can predict long-term outcome [12, 27, 29], and whether it can differentiate AMAN from AIDP [27, 30]. Here, GFAP is linked to Guillain-Barre syndrome, familial.